Wearable health technology company Oura has announced a major expansion of its strategic partnership with artificial intelligence-native primary care provider Counsel. The collaboration is entering a new phase through the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model. This federal initiative provides a formalized framework for Oura and Counsel to evaluate, at an unprecedented scale, how continuous biometric data captured by consumer wearables can be effectively integrated with physician-led medical interventions to support aging populations managing complex, long-term health conditions.

Beginning in early 2027, Counsel will roll out specialized, AI-native chronic disease management services targeted at conditions such as hypertension, obesity, hyperlipidemia, and prediabetes. Crucially, these services will be provided at no out-of-pocket cost to eligible Medicare beneficiaries residing across nearly all United States jurisdictions. The initiative bridges the gap between passive health monitoring and proactive medical management, offering a glimpse into the future of tech-enabled geriatric care.

The Genesis of the Partnership: From Consumer Insights to Clinical Action

The latest agreement builds upon a foundational partnership established in May of the same year. That initial collaboration was designed to solve a persistent challenge in the consumer health technology landscape: helping users transition seamlessly from passive self-monitoring to actionable clinical follow-up. While smart rings and fitness trackers have proliferated over the past decade, users have historically been left to interpret complex streams of physiological data independently, often struggling to determine when minor metric fluctuations warrant professional medical attention.

By integrating Counsel’s medical artificial intelligence and network of board-certified physicians directly into the Oura ecosystem, the companies created a bridge between daily behavioral health metrics and professional clinical oversight. Oura members were given the ability to connect their continuous health insights—ranging from sleep architecture and heart rate variability to temperature trends and activity levels—with on-demand telehealth consultations.

Early performance metrics from this initial integration have demonstrated strong user adoption and satisfaction. Oura members who utilized the Counsel integration to consult with a physician have rated their overall care experience at an impressive 4.6 out of 5 stars. Users have repeatedly emphasized the utility of the service in helping them contextualize complex biometric data streams and formulate clear, structured health strategies in collaboration with licensed medical professionals.

The ACCESS Model: Scaling Digital Health for Medicare

The transition from a consumer-focused integration to participation in the CMS ACCESS Model represents a significant scaling of this model into the heavily regulated federal healthcare sector. The CMS Innovation Center, established under the Affordable Care Act, is tasked with testing innovative payment and service delivery models that have the potential to reduce program expenditures while preserving or enhancing the quality of care for beneficiaries enrolled in Medicare, Medicaid, or the Children’s Health Insurance Program (CHIP).

Chronic disease management remains one of the largest cost drivers within the American healthcare system. Conditions such as hypertension and obesity disproportionately affect older Americans, contributing to higher rates of cardiovascular events, kidney disease, and metabolic disorders. Traditional models of chronic care management often rely on episodic office visits and retrospective data collection, which can fail to capture acute physiological shifts in real time.

Under the ACCESS Model framework, Oura and Counsel will study how continuous, passive biometric data collection can alter this paradigm. By feeding continuous Oura Ring data—with explicit patient consent—into Counsel’s AI-native care delivery infrastructure, healthcare providers gain continuous visibility into patient trends. This allows care teams to intervene earlier, adjust treatment plans dynamically, and engage patients before minor physiological deviations escalate into severe, costly medical emergencies.

Demographics and Target Populations: Why Seniors and Wearables Match

A common misconception in the consumer technology sector is that older demographics are slow to adopt digital health tools. However, empirical data from Oura challenges this narrative. Users aged 65 and older represent one of the platform’s most highly engaged cohorts, demonstrating exceptional daily application engagement rates and consistent wearing habits.

This high level of baseline engagement provides an ideal foundation for longitudinal health studies and continuous care programs. Furthermore, demographic analyses within the Oura ecosystem reveal high clinical relevance: approximately 20% of Oura members within the senior age bracket present with a Body Mass Index (BMI) of 30 or higher. This prevalence of obesity underscores the pressing need for scalable, accessible lifestyle and clinical interventions targeting cardio-kidney-metabolic health within this population.

By aligning the continuous accuracy of Oura’s biometric tracking hardware with the personalized, on-demand support of Counsel’s clinical team, the partnership addresses the specific needs of a demographic that often manages multiple chronic conditions simultaneously. The program is designed to deliver a level of continuous care coordination that matches the medical complexity of the patients it serves.

Official Perspectives and Industry Implications

Leadership from both organizations have highlighted the broader systemic significance of the expanded collaboration.

“Earlier in the year, we partnered with Counsel to help Oura Members move from health insights to clinical action,” said Dr. Ricky Bloomfield, Chief Medical Officer at Oura. “The ACCESS program gives us the opportunity to study that model at scale, and to better understand how continuous biometric data, combined with physician-led care, can support Medicare beneficiaries managing hypertension, obesity, and other early cardio-kidney-metabolic conditions.”

Industry analysts view the partnership as a potential watershed moment for the intersection of consumer technology and federal healthcare reimbursement structures. For years, major technology companies have sought pathways to integrate consumer hardware data into formal clinical settings, facing hurdles related to data privacy, interoperability, and regulatory compliance. By participating in a federally sanctioned innovation model like ACCESS, Oura and Counsel are establishing a formalized blueprint for how consumer health data can be safely leveraged within government-backed insurance programs.

The broader implications extend to the evolving role of artificial intelligence in primary care. Counsel’s proprietary medical AI acts as an administrative and analytical triage layer, processing vast quantities of continuous biometric data to surface actionable insights for human clinicians. This configuration aims to mitigate physician burnout, reduce administrative friction, and ensure that clinical time is spent on high-value patient interactions rather than manual data review.

Chronology and Rollout Timeline

  • May: Oura and Counsel announce their initial consumer partnership, enabling Oura members to connect app insights with on-demand physician-led care.
  • Late Year: Initial integration reports strong reception, with participating members rating their clinical experiences 4.6 out of 5 stars.
  • Current Announcement: Oura and Counsel announce their participation in the CMS Innovation Center’s ACCESS Model, officially expanding their framework to Medicare beneficiaries.
  • Early 2027: Official launch of Counsel’s AI-native chronic care delivery for eligible Medicare beneficiaries across nearly all U.S. states at no out-of-pocket cost.

Enrollment Process and Next Steps

As the program approaches its 2027 launch date, structured pathways for participation are being developed. Oura will utilize the Oura App as an informational and connective hub, alerting interested members to the availability of the ACCESS program and facilitating introductions to Counsel.

However, clinical qualification and enrollment will remain strictly independent. Counsel will independently verify the clinical eligibility of prospective participants based on CMS guidelines, manage official program enrollment, and oversee all aspects of patient care delivery. Further operational details and step-by-step enrollment instructions will be communicated directly to eligible Oura members through the Oura App as the 2027 rollout approaches.

Ultimately, the partnership between Oura and Counsel under the CMS ACCESS Model signals a maturation of the digital health sector—moving away from isolated wellness tracking and toward deeply integrated, evidence-based medical ecosystems designed to meet the complex demands of an aging population.

Leave a Reply

Your email address will not be published. Required fields are marked *